The Indian rupee weakened to a historic low of 87.35 against the U.S. dollar, influenced by expectations of an impending rate cut by the Reserve Bank of India and strong dollar demand from importers. Despite a softer dollar aiding other Asian currencies, India’s persistent foreign portfolio outflows added further pressure, resulting in nearly 0.3% depreciation on the day.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.
April 27, 2026